The American Journal of Managed Care

Clinicians Should Look Beyond NGS When Delivering Precision Oncology: Joshua K. Sabari, MD

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
ascopubs.org

Paired matched normal sequencing to accurately identify somatic clonal hematopoiesis mutations (CHm) in solid tumor tissue and plasma specimens.

ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). Characterization of molecular response and progression ...

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing

What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...
ascopubs.org

Next-generation sequencing of FFPE solid tumor specimens for clinical use.

Prognostic significance of LINE-1 methylation level in the upper gastrointestinal cancer. Prospective study of oncogenic mutations in circulating cell-free DNA (cfDNA) using a multiplex sequencing ...
Labroots

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors

Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical ...